Healthcare associated infections caused by coagulase-negative Staphylococci in a neonatal intensive care unit
- PMID: 24213088
- PMCID: PMC4031843
- DOI: 10.5935/0103-507X.20130041
Healthcare associated infections caused by coagulase-negative Staphylococci in a neonatal intensive care unit
Abstract
Objective: This study sought to evaluate infections related to health care caused by coagulase-negative Staphylococci in a neonatal intensive care unit by assessing antimicrobial susceptibility profiles and potentially effective antibiotic regimens.
Methods: This was a retrospective descriptive study performed on a case series of healthcare-associated infections, and the antimicrobial susceptibility profiles were evaluated. Newborns from other hospitals who were admitted to a neonatal intensive care unit in Rio de Janeiro between January 1, 2010, and June 30, 2012, were studied.
Results: In total, 765 patients were admitted, totaling 3,051 patient-days, and the incidence density of general infection was 18.9 per 1,000 patient-days. The rate of central venous catheter use was 71.6%, and the positive culture rate for all sites and all infections related to health care were 68.4%. Coagulase-negative Staphylococci were identified in 11 (19.2%) of 57 health care-related infections, and infections with extended-spectrum beta-lactamase producing Klebsiella pneumoniae and Candida sp. constituted 5 cases each. Of the 11 cases of coagulase-negative Staphylococci, 10 (90.9%) were primary bloodstream infections. The sensitivity of the coagulase-negative Staphylococci isolates to vancomycin, clindamycin, ciprofloxacin, oxacillin and gentamycin was 100%, 81.8%, 72.7%, 27.2% and 22.2%, respectively. There were no deaths directly attributed to coagulase-negative Staphylococci infection.
Conclusion: Coagulase-negative Staphylococci was the main agent identified in healthcare-associated infections, with low rates of infections related to central venous catheter. In hospitals with a high oxacillin resistance profile, similar to those included in this study, vancomycin may be used as an initial therapy, although clindamycin represents a viable alternative.
Objetivo: Avaliar as infecções relacionadas à assistência à saúde, em unidade de terapia intensiva neonatal, causadas pelo Staphylococcus coagulase negativa, verificando o perfil de sensibilidade antimicrobiana e possíveis esquemas antibióticos eficazes.
Métodos: Estudo descritivo retrospectivo de uma série de casos de infecções relacionadas à assistência à saúde tardias de origem hospitalar atribuída ao Staphylococcus coagulase negativa, avaliando o perfil de sensibilidade antimicrobiana. Foram estudados os recém-nascidos internados entre 1º de janeiro de 2010 a 30 de junho de 2012 em uma unidade de terapia intensiva neonatal da cidade do Rio de Janeiro, sendo todos os pacientes oriundos de outras unidades.
Resultados: Foram admitidos 765 pacientes, totalizando 3.051 pacientes-dia e uma densidade de incidência de infecção geral de 18,9 por 1.000 pacientes-dia. A taxa de utilização de cateteres venosos centrais foi de 71,6% e a positividade das culturas de todos os sítios para todas as infecções relacionadas à assistência à saúde foi de 68,4%. O Staphylococcus coagulase negativa foi implicado em 11 (19,2%) das 57 infecções relacionadas à assistência à saúde e Klebsiela pneumoniae produtor de betalactamase de espectro estendido e Candida sp em 5 ocasiões cada. Das 11 infecções, 10 (90,9%) foram atribuídas a infecções primárias de corrente sanguínea. A sensibilidade dos isolados de Staphylococcus coagulase negativa em relação à vancomicina, clindamicina, ciprofloxacin, oxacilina e gentamicina foi de 100%, 81,8%, 72,7%, 27,2%, 22,2%, respectivamente. Não houve óbito atribuído diretamente à infecção por Staphylococcus coagulase negativa.
Conclusão: O Staphylococcus coagulase negativa foi o principal agente encontrado nas infecções relacionadas à assistência à saúde tardias de origem hospitalar, sendo baixas as taxas de infecções relacionadas a cateter venoso central. Em hospitais semelhantes ao aqui estudado, com elevado perfil de resistência à oxacilina, a vancomicina pode ser utilizada como terapêutica inicial, sendo também a clindamicina uma alternativa viável.
Conflict of interest statement
Figures
Similar articles
-
Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.Ann Clin Microbiol Antimicrob. 2017 Sep 19;16(1):63. doi: 10.1186/s12941-017-0238-5. Ann Clin Microbiol Antimicrob. 2017. PMID: 28927452 Free PMC article.
-
Trends of Antimicrobial Susceptibility in Clinically Significant Coagulase-Negative Staphylococci Isolated from Cerebrospinal Fluid Cultures in Neurosurgical Adults: a Nine-Year Analysis.Microbiol Spectr. 2022 Feb 23;10(1):e0146221. doi: 10.1128/spectrum.01462-21. Epub 2022 Feb 9. Microbiol Spectr. 2022. PMID: 35138154 Free PMC article.
-
Clinical significance of coagulase-negative staphylococci isolates from nosocomial bloodstream infections.Infect Dis (Lond). 2016;48(5):356-60. doi: 10.3109/23744235.2015.1122833. Epub 2015 Dec 15. Infect Dis (Lond). 2016. PMID: 26666168
-
Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: limitations of present therapy.Clin Microbiol Infect. 2001;7 Suppl 4:1-7. doi: 10.1046/j.1469-0691.2001.00053.x. Clin Microbiol Infect. 2001. PMID: 11688530 Review.
-
Current problems of chemotherapy of infections with coagulase-negative staphylococci.Eur J Clin Microbiol. 1986 Jun;5(3):277-81. doi: 10.1007/BF02017781. Eur J Clin Microbiol. 1986. PMID: 3527698 Review.
Cited by
-
Neonatal healthcare-associated infections in Brazil: systematic review and meta-analysis.Arch Public Health. 2021 Jun 1;79(1):89. doi: 10.1186/s13690-021-00611-6. Arch Public Health. 2021. PMID: 34074325 Free PMC article. Review.
-
Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections.Exp Ther Med. 2018 Dec;16(6):4499-4510. doi: 10.3892/etm.2018.6737. Epub 2018 Sep 14. Exp Ther Med. 2018. PMID: 30542398 Free PMC article.
-
Antimicrobial resistance and virulence determinants in coagulase-negative staphylococci isolated mainly from preterm neonates.PLoS One. 2020 Aug 4;15(8):e0236713. doi: 10.1371/journal.pone.0236713. eCollection 2020. PLoS One. 2020. PMID: 32750089 Free PMC article.
References
-
- Brasil. Agência Nacional de Vigilância Sanitária (Anvisa) Critérios Nacionais de Infecções Relacionadas à Assistência à Saúde. Brasília: Anvisa; 2010.
-
- Hemels MA, van den Hoogen A, Verboon-Maciolek MA, Fleer A, Krediet TG. A seven-year survey of management of coagulase-negative staphylococcal sepsis in the neonatal intensive care unit: vancomycin may not be necessary as empiric therapy. Neonatology. 2011;100(2):180–185. - PubMed
-
- Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pt 1Pediatrics. 2002;110(2):285–291. - PubMed
-
- van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2010;97(1):22–28. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical